CSBR
Champions Oncology
$4.81
−$0.11 (−2.24%)Oct 29, 2026
Key metrics
The numbers that frame CSBR today
- Market cap
- $66.95M
- Gross margin
- 49.8%
- EV / Sales
- 1.2
- ROIC
- -9.5%
- Div yield
- 0%
- Debt / equity
- 2.7
- 52wk Low
- $4.59
- 52wk High
- $8.31
Growth
Revenue and earnings trend for CSBR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CSBR
Is Champions Oncology a good buy?
Yes. Champions Oncology has strong quality, and it outweighs the poor momentum here. Growth looks strong, which supports the long-term business case. We think Champions Oncology is selling at a high price, which cuts against the buy case.
What is the market capitalization of CSBR?
Champions Oncology's market capitalization is $66.95M.
What is the 52-week high for CSBR stock?
The 52-week high for Champions Oncology is $8.31. The current close of $4.81 is 42.1% below that high.
What is the 52-week low for CSBR stock?
The 52-week low for Champions Oncology is $4.59. The current close of $4.81 is 4.8% above that low.
Does CSBR stock pay dividends?
Champions Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CSBR?
Champions Oncology's Debt / Equity ratio is 2.7.